drugset / Trial / NCT01084876
Demonstrate Efficacy and Safety of Metastatic Breast Cancer
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to demonstrate equivalence
Timeline
- Start
- 2010-06
- Primary completion
- 2012-07
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Trastuzumab | Monoclonal antibody | 6 mg/kg | Intravenous |
| Background | Paclitaxel | Small molecule | 175 mg/m2 | Intravenous |